Barclays Initiates Coverage On Boston Scientific with Equal-Weight Rating, Announces Price Target of $48
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice TargetHot
Barclays analyst Christopher Pasquale initiates coverage on Boston Scientific (NYSE:BSX) with a Equal-Weight rating and announces Price Target of $48.
Barclays analyst Christopher Pasquale initiates coverage on Boston Scientific (NYSE:BSX) with a Equal-Weight rating and announces Price Target of $48.